Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Impact of Elotuzumab Plus Pomalidomide/Dexamethasone on Health-Related Quality of Life for Patients with Relapsed/Refractory Multiple Myeloma (RRMM): Final Data from the Phase 2 ELOQUENT-3 Trial

Katja Weisel, Meletios A. Dimopoulos, Jesús San-Miguel, Agne Paner, Monika Engelhardt, Fiona Taylor, Jennifer Lord-Bessen, David Yao, Christine Yip, Mike Greenwood, Jackson Tang, Michele Cavo

Blood (2021) 138 (Supplement 1): 1662.

https://doi.org/10.1182/blood-2021-145310

Published: 2021

Journal Articles

Low Dose Antithymocyte Globulin (ATG) for Graft-Versus-Host Disease (GVHD) Prophylaxis

Anand Tandra, MD, Leland Metheny, MD, David Yao, MD PhD, Paolo F. Caimi, MD, Lauren Brister, CNP, Brenda Cooper, MD, Hillard M. Lazarus, MD, Ben K. Tomlinson, MD, Ehsan Malek, MD, Fahrettin Covut, MD, Raisa Pinto, MD, Marcos deLima, MD

Blood (2016) 128 (22): 5788.

https://doi.org/10.1182/blood.V128.22.5788.5788

Published: 2016

Journal Articles

Pegfilgrastim Use and Risk of Bleomycin Induced Pulmonary Toxicity in Hodgkin Lymphoma

David Yao, MD PhD, Murali Janakiram, MD, Timothy E. O'Brien, MD

Blood (2016) 128 (22): 5350.

https://doi.org/10.1182/blood.V128.22.5350.5350

Published: 2016

Journal Articles

Protein O -fucosyltransferase 1 (Pofut1) regulates lymphoid and myeloid homeostasis through modulation of Notch receptor ligand interactions

David Yao, Yuanshuai Huang, Xiaoran Huang, Weihuan Wang, Quanjian Yan, Lebing Wei, Wei Xin, Stanton Gerson, Pamela Stanley, John B. Lowe, Lan Zhou

Blood (2011) 117 (21): 5652–5662.

https://doi.org/10.1182/blood-2010-12-326074

Published: 2011

Includes: Supplemental data

Journal Articles

Notch-Dependent Control of Blood Lineage Development is Modified by Fucosylation

Lan Zhou, MD, PhD, Quanjian Yan, David Yao, Lebing W Li, Stanton L. Gerson, MD, John B Lowe, MD

Blood (2008) 112 (11): 2448.

https://doi.org/10.1182/blood.V112.11.2448.2448

Published: 2008

NARROW

Impact of Elotuzumab Plus Pomalidomide/Dexamethasone on Health-Related Quality of Life for Patients with Relapsed/Refractory Multiple Myeloma (RRMM): Final Data from the Phase 2 ELOQUENT-3 Trial

Low Dose Antithymocyte Globulin (ATG) for Graft-Versus-Host Disease (GVHD) Prophylaxis

Pegfilgrastim Use and Risk of Bleomycin Induced Pulmonary Toxicity in Hodgkin Lymphoma

Protein O -fucosyltransferase 1 (Pofut1) regulates lymphoid and myeloid homeostasis through modulation of Notch receptor ligand interactions

Notch-Dependent Control of Blood Lineage Development is Modified by Fucosylation

Email alerts

ASH Publications

American Society of Hematology

Impact of Elotuzumab Plus Pomalidomide/Dexamethasone on Health-Related Quality of Life for Patients with Relapsed/Refractory Multiple Myeloma (RRMM): Final Data from the Phase 2 ELOQUENT-3 Trial

Low Dose Antithymocyte Globulin (ATG) for Graft-Versus-Host Disease (GVHD) Prophylaxis

Pegfilgrastim Use and Risk of Bleomycin Induced Pulmonary Toxicity in Hodgkin Lymphoma

Protein O -fucosyltransferase 1 (Pofut1) regulates lymphoid and myeloid homeostasis through modulation of Notch receptor ligand interactions

Notch-Dependent Control of Blood Lineage Development is Modified by Fucosylation

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only